Updated

Updated · BIOENGINEER.ORG · Jul 10

Repeat PSMA PET Scans Change Treatment in Nearly 50% of 210 Prostate Recurrence Cases

Updated

Updated · BIOENGINEER.ORG · Jul 10

Repeat PSMA PET Scans Change Treatment in Nearly 50% of 210 Prostate Recurrence Cases

Q: What hidden cancer is a repeat scan finding that the first test completely missed?

The repeat scan is finding **recurrent prostate cancer that was initially occult**, especially **small-volume metastatic disease such as oligometastatic lesions in lymph nodes or bone**, and in some cases **local recurrence**. In the study, patients had rising PSA levels after prior treatment but a negative first PSMA PET scan. When they underwent a second PSMA PET/CT, **56% showed previously undetected cancer**. The newly found disease ranged from recurrence confined to the original area to more extensive metastatic spread. The most clinically important hidden cancer was **oligometastatic recurrence**—a limited number of metastatic lesions that can be targeted with focused treatment such as stereotactic radiotherapy. That matters because these are exactly the kinds of lesions that can change management: nearly **half of patients had their treatment plan altered** after the repeat scan. The evidence suggests the first scan did not mean there was no cancer; in many cases, the disease was simply **too small or biologically less visible at that time**. Patients with **higher PSA levels and faster PSA doubling times** were more likely to have a positive second scan, indicating that repeat imaging can uncover recurrence that becomes detectable as the cancer burden grows.

3 articles · Updated · BIOENGINEER.ORG · Jul 10

A second PSMA PET/CT scan changed clinical management in nearly half of 210 prostate cancer patients whose first scan was negative despite rising PSA levels.
The repeat scan detected disease in 56% of those patients, uncovering localized, locoregional, oligometastatic and extensive metastatic recurrence that had been missed initially.
Higher PSA levels and PSA doubling times under 12 months were linked to a greater chance of a positive second scan, pointing to when repeat imaging may be most useful.
The findings, published in the Journal of Nuclear Medicine from an Ontario multicenter registry, support adding repeat PSMA PET/CT to routine care for biochemical recurrence after surgery or radiation.

Sources

BIOENGINEER.ORG2d ago

Repeat PSMA PET Scans Alter Treatment for Nearly 50% of Prostate Cancer Recurrence Patients

National Institutes of Health (NIH) (.gov)2d ago

Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging - PMC

nejm.org2d ago

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer | New England Journal of Medicine

6 Sources

After a 'clear' cancer scan, why are treatment plans for half of patients now being changed?

What hidden cancer is a repeat scan finding that the first test completely missed?

How Repeat PSMA PET Scans and PSA Kinetics Are Changing the Game in Recurrent Prostate Cancer Care

Overview

A groundbreaking July 2026 study published in The Journal of Nuclear Medicine is set to change how recurrent prostate cancer is managed. The research followed 210 patients from the Ontario registry who had more than one PSMA PET scan after an initial negative result. By comparing scan positivity rates, PSA levels, PSA doubling times, and changes in patient management after the second scan, the study highlighted the critical role of repeat PSMA PET scans in detecting disease progression and guiding treatment decisions. These findings mark a shift toward more precise, personalized strategies and offer renewed hope for better patient outcomes.

...